BSE Live
Nov 14, 16:01Prev. Close
417.05
Open Price
415.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:57Prev. Close
417.00
Open Price
414.75
Bid Price (Qty.)
411.15 (7561)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Biocon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 436.30 | 492.70 | 238.50 | 519.30 | 368.60 | |
| Net CashFlow From Operating Activities | 387.10 | 109.50 | 355.20 | 185.80 | 208.50 | |
| Net Cash Used In Investing Activities | -212.90 | 310.90 | -555.50 | 110.40 | -321.10 | |
| Net Cash Used From Financing Activities | -128.90 | -208.20 | -54.60 | -238.30 | 73.00 | |
| Foreign Exchange Gains / Losses | 24.00 | 4.40 | 2.40 | -6.40 | 7.80 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 69.30 | 216.60 | -252.50 | 51.50 | -31.80 | |
| Cash And Cash Equivalents Begin of Year | 305.70 | 89.10 | 341.60 | 290.10 | 321.90 | |
| Cash And Cash Equivalents End Of Year | 375.00 | 305.70 | 89.10 | 341.60 | 290.10 |
14.11.2025
12.11.2025
Biocon Standalone September 2025 Net Sales at Rs 583.30 crore, up 11.02% Y-o-Y
10.11.2025
07.11.2025